Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus bupivacaine adductor canal block for pain after knee replacement
ChiCTR2400090965Phase 4Recruiting
- Sponsor
- Bazhong Central Hospital
- Start
- Oct 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine and bupivacaine in postoperative pain (2 arms), sponsored by Bazhong Central Hospital. Primary endpoint: Incidence of rebound pain within 24 hours after surgery. Started Oct 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400090965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090965.